Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
Centre Hospitalier Universitaire de Liège · Inserm · +15 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
592
total citations
- FWCI
- 32.68
- Percentile
- 100%
- References
- 44
Citations per year
Authors
19- ÉLÉdouard LouisCorresponding
Centre Hospitalier Universitaire de Liège
- JMJean‐Yves Mary
Inserm, Délégation Paris 7, Université Paris Cité
- GVGwénola Vernier-Massouille
Université Lille Nord de France
- JGJean–Charles Grimaud
Hôpital Nord
- YBYoram Bouhnik
Délégation Paris 7, Université Paris Cité, Hôpital Beaujon
Topics & keywords
Topics
Keywords
- Infliximab
- Medicine
- Antimetabolite
- Internal medicine
- Surgery
- Crohn's disease
- Maintenance therapy
- Population
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.